AMG
54
-4
EMN
55
2
DNB
52
2
ISRG
71
-5
ICE
64
-2
WYNN
42
-6
FAST
56
-3
ZION
65
-4
WU
38
2
SLG
56
-3
HD
55
-3
EXPD
32
-5
HST
43
-4
PFG
50
-3
FRT
56
-2
SJM
29
5
CMG
48
-2
WM
73
2
BMY
51
3
AN
52
-6
AMG
54
-4
EMN
55
2
DNB
52
2
ISRG
71
-5
ICE
64
-2
WYNN
42
-6
FAST
56
-3
ZION
65
-4
WU
38
2
SLG
56
-3
HD
55
-3
EXPD
32
-5
HST
43
-4
PFG
50
-3
FRT
56
-2
SJM
29
5
CMG
48
-2
WM
73
2
BMY
51
3
AN
52
-6
Financhill
Back

Morningstar 10K Form

Buy
61

MORN
Morningstar

Last Price:
$305.87
Seasonality Move:
4.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MORN News And Ratings

See the #1 stock for the next 7 days that we like better than MORN

MORN Financial Statistics

Sales & Book Value

Annual Sales: $2.3B
Cash Flow: $58.8M
Price / Cash Flow: 29.87
Annual Sales: $37.86
Price / Book: 8.15

Profitability

EPS (TTM): 8.90000
Net Income (TTM): $384.2M
Gross Margin: $1.4B
Return on Equity: 25.24%
Return on Assets: 10.98%

Morningstar Earnings Forecast

Key Morningstar Financial Ratios

  • The Gross Profit Margin over the past 23 years for MORN is 60.63%.
  • The Selling, General & Administrative Expenses for MORN have been equal to 33.77% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 13.49% of Operating Income.
  • The Net Earning history of MORN is 16.26% of Total Revenues.
  • Per Share Earnings over the last 25 years have been positive in 17 years.

Morningstar Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Capital Markets
Sector: Financials
Current Symbol: MORN
CUSIP: 617700
Website: morningstar.com

Debt

Debt-to-Equity Ratio: 0.5
Current Ratio: 1.11
Quick Ratio: 1

Price-to-Earnings

Trailing P/E Ratio: 36.18
Forward P/E Ratio: 29.62

MORN Technical Analysis vs Fundamental Analysis

Buy
61
Morningstar (MORN) is a Buy

Is Morningstar a Buy or a Sell?

  • Morningstar stock is rated a Buy
    The current Morningstar [MORN] share price is $310.44. The Score for MORN is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.